Galecto Inc.(GLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GLTO Galecto Inc.

Closed New Year's Day 12-31 16:00:00 EST

23.01

+0.70

+3.14%

盘后24.42

+1.41+6.13%

18:47 EST

High24.75	Low22.33	Vol33.46K
Open23.00	D1 Closing22.31	Amplitude10.85%
Mkt Cap36.70M	Tradable Cap27.46M	Total Shares1.60M
T/O786.56K	T/O Rate2.80%	Tradable Shares1.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GLTO","market":"US","secType":"STK","nameCN":"Galecto Inc.","latestPrice":23.01,"timestamp":1767214800000,"preClose":22.31,"halted":0,"volume":33459,"hourTrading":{"tag":"盘后","latestPrice":24.42,"preClose":23.01,"latestTime":"18:47 EST","volume":256,"amount":6103.68,"timestamp":1767224836748},"delay":0,"floatShares":1193300,"shares":1595161,"eps":-11.990068,"marketStatus":"Closed New Year's Day","change":0.7,"latestTime":"12-31 16:00:00 EST","open":23,"high":24.7499,"low":22.33,"amount":786556.012245,"amplitude":0.108467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-11.990068,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767344400000},"marketStatusCode":7,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":22.31,"preHourTrading":{"tag":"盘前","latestPrice":23.7,"preClose":22.31,"latestTime":"09:25 EST","volume":405,"amount":9597.184965,"timestamp":1767191110005},"postHourTrading":{"tag":"盘后","latestPrice":24.42,"preClose":23.01,"latestTime":"18:47 EST","volume":256,"amount":6103.68,"timestamp":1767224836748},"volumeRatio":0.32865994005092614,"impliedVol":1.2797,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GLTO/tweets","defaultTab":"tweets","newsList":[{"id":"2600670169","title":"Galecto Files to Register 60.5 Million Shares for Secondary Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2600670169","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600670169?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:26","pubTimestamp":1767216410,"startTime":"0","endTime":"0","summary":"Galecto (GLTO) filed a registration statement late Wednesday for a secondary offering of 60.5 million common shares by selling stockholders.The company will not receive any proceeds from the offering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2592895847","title":"BRIEF-Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2592895847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592895847?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:20","pubTimestamp":1765923623,"startTime":"0","endTime":"0","summary":"BRIEF-Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Dec 16 (Reuters) - Galecto Inc GLTO.O:GALECTO, INC. ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)So","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA87QGX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2590599322","title":"Galecto Issues Correction to Series C Preferred Stock Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590599322","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590599322?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:00","pubTimestamp":1765317657,"startTime":"0","endTime":"0","summary":"Galecto Inc. has filed an amendment to its previous report to disclose the filing of a certificate of correction for its Series C Preferred Stock designation, addressing an error in the original certificate with the Delaware Secretary of State.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galecto Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL7M4rQg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2589355791","title":"Galecto Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2589355791","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589355791?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:44","pubTimestamp":1765201440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLTO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 08:44 ET (13:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLTO"],"gpt_icon":0},{"id":"2588395720","title":"Galecto Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2588395720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588395720?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:59","pubTimestamp":1764593940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLTO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 01, 2025 07:59 ET (12:59 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2588727331","title":"Guggenheim Initiates Coverage on Galecto With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727331","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588727331?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:33","pubTimestamp":1764592385,"startTime":"0","endTime":"0","summary":"Galecto (GLTO) has an average rating of Buy and mean price target of $32, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and rese","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLTO"],"gpt_icon":0},{"id":"2584929954","title":"Galecto Q3 Operating Income USD -3.156 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929954","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929954?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:59","pubTimestamp":1763571548,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Galecto Q3 basic EPS USD -2.36.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:30:46.39 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD5GJdxx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2584604258","title":"Galecto Inc. Files Initial Beneficial Ownership Statement for Director Bruno Julianne","url":"https://stock-news.laohu8.com/highlight/detail?id=2584604258","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584604258?lang=en_us&edition=fundamental","pubTime":"2025-11-18 10:45","pubTimestamp":1763433900,"startTime":"0","endTime":"0","summary":"Galecto Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Bruno Julianne as the beneficial owner, serving in the role of Director at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galecto Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL9HvyMj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2582394552","title":"Galecto Shares up 70% at $29.53 After Resuming Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2582394552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582394552?lang=en_us&edition=fundamental","pubTime":"2025-11-12 03:34","pubTimestamp":1762889669,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nL6N3WN0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2582394212","title":"Galecto trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2582394212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582394212?lang=en_us&edition=fundamental","pubTime":"2025-11-12 03:25","pubTimestamp":1762889133,"startTime":"0","endTime":"0","summary":"14:20 EST Galecto (GLTO) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galecto-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galecto-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2582017718","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2582017718","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582017718?lang=en_us&edition=fundamental","pubTime":"2025-11-11 02:44","pubTimestamp":1762800265,"startTime":"0","endTime":"0","summary":"Galecto (GLTO) shares soared 229% after the company said Monday it completed the acquisition of Damora Therapeutics.Intraday trading volume soared to nearly 35.7 million shares from a daily average of","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4170","GLTO","BK4139","BK4505","MOVE","COGT"],"gpt_icon":0},{"id":"2582805772","title":"Gold Jumps Over 2%; Dole Shares Gain After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582805772","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582805772?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:01","pubTimestamp":1762794113,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/11/48758872/gold-jumps-over-2-dole-shares-gain-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","NQmain","LU1721429402.USD","SGRY","TSYW.SI","BK4170","GLTO","USAW.SI","BK4124","BK4214","QLD","LU1721429741.USD","DOLE","BK4505","BK4139","MPAA","COGT","MNQmain","GORV","BK4539","BK4185","NVIW.SI","MOVE","BK4212","TQQQ","PSQ","SQQQ","QID",".IXIC"],"gpt_icon":1},{"id":"2582871283","title":"Galecto Inc. Unveils Acquisition Details and Pipeline Milestones Following Damora Therapeutics Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871283","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871283?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:26","pubTimestamp":1762781217,"startTime":"0","endTime":"0","summary":"Galecto Inc. has announced the acquisition of Damora Therapeutics in a stock-for-stock transaction, exchanging all of Damora's outstanding equity for a combination of Galecto common stock and newly created Series C convertible preferred stock. Concurrent with the acquisition, Galecto completed a $285 million private placement led by Fairmount and a syndicate of biotechnology investors. The proceeds are expected to advance Damora's pipeline, including proof-of-concept data for DMR-001 and DMR-002 and an IND filing for DMR-003, with a projected cash runway into 2029. The leadership team will include Hans Schambye, Matthew Kronmiller, Lori Firmani, and Garrett Winslow, with new board members from Fairmount joining the existing board. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL30bwXD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2582879502","title":"Why Is Galecto Stock (GLTO) Up 285% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879502?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:52","pubTimestamp":1762779133,"startTime":"0","endTime":"0","summary":"Galecto stock soared on Monday after it bought Damora Therapeutics and completed a funding round.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-galecto-stock-glto-up-285-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-galecto-stock-glto-up-285-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2582876527","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876527","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876527?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:38","pubTimestamp":1762778311,"startTime":"0","endTime":"0","summary":"Galecto (GLTO) stock was up more than four-fold pre-bell Monday after the company said it has acquired biotechnology firm Damora Therapeutics.TreeHouse Foods (THS) shares were 20% higher after the com","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RUM","GLTO","BK4212","BK4077","THS","BK4139","BK4516"],"gpt_icon":0},{"id":"2582873565","title":"Galecto Inc - Combined Company Expected to Have Financial Runway Into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873565?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA790QK2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLTO","BK4139"],"gpt_icon":0},{"id":"2582873563","title":"Galecto Inc - Phase 1 Proof-of-Concept Data for Dmr-001 Anticipated in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873563?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA790QK2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2582879840","title":"Galecto Announces Acquisition of Damora Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879840","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879840?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184348/0/en/Galecto-Announces-Acquisition-of-Damora-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","BK4109","BK4539","BK4561","BK4581","BK4007","BK4588","BK4585","BK4590","LENZ","BK4144","BK4226","BK4106","GLTO","XELA","LU2463526074.USD","ET","BK4139"],"gpt_icon":0},{"id":"2581108022","title":"Galecto, Inc. Reports Strategic Shift and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581108022","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581108022?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:29","pubTimestamp":1762489782,"startTime":"0","endTime":"0","summary":"Galecto, Inc. ( ($GLTO) ) has released its Q3 earnings. Here is a breakdown of the information Galecto, Inc. presented to its investors. Galecto, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galecto-inc-reports-strategic-shift-and-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galecto-inc-reports-strategic-shift-and-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLTO"],"gpt_icon":0},{"id":"2581049566","title":"Cancer drug developer Galecto's Q3 net loss narrows to $3.1 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581049566","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581049566?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:20","pubTimestamp":1762467601,"startTime":"0","endTime":"0","summary":"Cancer drug developer Galecto's Q3 net loss narrows to $3.1 mlnOverviewGalecto Q3 net loss narrows to $3.1 mln from $3.9 mln last yearCompany's cash reserves expected to fund GB3226 preclinical develo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLTO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.galecto.com","stockEarnings":[{"period":"1week","weight":-0.2197},{"period":"1month","weight":0.2949},{"period":"3month","weight":4.8253},{"period":"6month","weight":5.5},{"period":"1year","weight":3.9484},{"period":"ytd","weight":3.9484}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.019},{"period":"6month","weight":0.0905},{"period":"1year","weight":0.1635},{"period":"ytd","weight":0.1635}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.139859},{"month":2,"riseRate":0.2,"avgChangeRate":-0.075749},{"month":3,"riseRate":0.4,"avgChangeRate":-0.105328},{"month":4,"riseRate":0,"avgChangeRate":-0.128225},{"month":5,"riseRate":0.4,"avgChangeRate":-0.011355},{"month":6,"riseRate":0.6,"avgChangeRate":0.064068},{"month":7,"riseRate":0.4,"avgChangeRate":0.030923},{"month":8,"riseRate":0.4,"avgChangeRate":-0.123358},{"month":9,"riseRate":0.6,"avgChangeRate":0.012323},{"month":10,"riseRate":0.4,"avgChangeRate":0.0502},{"month":11,"riseRate":0.5,"avgChangeRate":0.174574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.010261}],"exchange":"NASDAQ","name":"Galecto Inc.","nameEN":"Galecto Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galecto Inc.(GLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Galecto Inc.(GLTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Galecto Inc.,GLTO,Galecto Inc.股票,Galecto Inc.股票老虎,Galecto Inc.股票老虎国际,Galecto Inc.行情,Galecto Inc.股票行情,Galecto Inc.股价,Galecto Inc.股市,Galecto Inc.股票价格,Galecto Inc.股票交易,Galecto Inc.股票购买,Galecto Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galecto Inc.(GLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Galecto Inc.(GLTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction